John W. Smither

Companies

• Attovia Therapeutics, Inc.Board member Aug 4, 2026 to now¹
• MBX Biosciences, Inc.Chief financial officer Mar 18, 2026 to now²
• NewAmsterdam Pharma Co N.V.Board member Dec 29, 2023 to now³
• GENELUX CorpBoard member Sep 13, 2023 to now⁴
• Arcutis Biotherapeutics, Inc.Chief financial officer Jan 30, 2020 to Feb 15, 2024⁵
• Applied Molecular Transport Inc.Board member Jan 31, 2022 to Dec 28, 2023⁶
• eFFECTOR Therapeutics, Inc.Board member Aug 27, 2021 to Jun 22, 2023⁷
• Arcutis Biotherapeutics, Inc.Board member Mar 3, 2020 to Mar 3, 2020⁸
• Principia Biopharma (United States)Board member Feb 21, 2019 to Feb 21, 2019⁹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ABArcutis Biotherapeutics, Inc. ARQT152,757 shares¹⁰$4.4M at $28.82Feb 15, 2024
• MBMBX Biosciences, Inc. MBX28,000 shares¹¹$1.4M at $50.71Aug 3, 2026
• GGENELUX Corp GNLX91,403 shares¹²$226.7K at $2.48Jul 1, 2026
• NPNewAmsterdam Pharma Co N.V. NAMS8,760 shares¹³$180.6K at $20.62Sep 4, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 4, 2026Sold 1,600 shares at $25.32 of NewAmsterdam Pharma Co N.V.¹³
• Aug 3, 2026Granted 28,000 shares of MBX Biosciences, Inc.¹¹
• Jul 1, 2026Sold 12,000 shares at $2.91 of GENELUX Corp¹²
• Jun 16, 2026Granted 28,409 shares of GENELUX Corp¹⁴
• Jan 7, 2026Granted 3,400 shares of NewAmsterdam Pharma Co N.V.¹⁵
• Aug 27, 2025Granted 22,283 shares of GENELUX Corp¹⁶
• Jan 7, 2025Granted 6,960 shares of NewAmsterdam Pharma Co N.V.¹⁷
• Aug 1, 2024Granted 39,541 shares of GENELUX Corp¹⁸
• May 29, 2024Bought 6,250 shares of GENELUX Corp¹⁹
• Feb 13, 2024Granted 8,572 shares of Arcutis Biotherapeutics, Inc.¹⁰
• Feb 13, 2024Granted 2,793 shares of Arcutis Biotherapeutics, Inc.¹⁰
• Sep 13, 2023Sold 900 shares at $20.78 of GENELUX Corp²⁰
• Sep 11, 2023Granted 6,920 shares of GENELUX Corp²¹